Expression of the urokinase plasminogen activator receptor (uPAR) and its ligand (uPA) in brain tissues of human immunodeficiency virus patients with opportunistic cerebral diseases

References

• Akenami FO, Koskiniemi M, Farkkila M, Vaheri A. Cerebrospinal fluid plasminogen activator inhibitor-1 in patients with neurological disease. J Clin Pathol 1997; 50: 157–160
   PubMed Web of Science ®Google Scholar
• Akenami FO, Siren V, Koskiniemi M, Siimes MA, Teravainen H, Vaheri A. Cerebrospinal fluid activity of tissue plasminogen activator in patients with neurological diseases. J Clin Pathol 1996; 49: 577–580
   Google Scholar
• Alfano M, Sidenius N, Panzere B, Blasi F, Poli G. Urokinase-urokinase receptor interaction mediates an inhibitor signal for HIV-1 replication. Proc Natl Acad Sci U S A 2002; 99: 8862–8867
   Google Scholar
• Brunner N, Nielsen HJ, Hamers M, Christensen IJ, Thorlacius-Ussing O, Stephens RW. The urokinase plasminogen activator receptor in blood from healthy individuals and patients with cancer. APMIS 1999; 107: 160–167
   PubMed Web of Science ®Google Scholar
• Cinque P, Nebuloni M, Santovito ML, Price RW, Gisslen M, Hagberg L, Bestetti A, Vago G, Lazzarin A, Blasi F, Sidenius N. The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations. Ann Neurol 2004; 55: 687–694
   PubMed Web of Science ®Google Scholar
• Cinque P, Vago L, Mengozzi M, Torri V, Ceresa D, Vicenzi E, Transidico P, Vagani A, Sozzoni S, Mantovani A, Lazzarin A, Poli G. Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS 1998; 12: 1327–1332
   PubMed Web of Science ®Google Scholar
• Coleman JL, Gebbia JA, Benach JL. Borrelia burgdoferi and other bacterial products induce expression and release of the urokinase receptor (CD87). J Immunol 2001; 166: 473–480
   PubMedGoogle Scholar
• Collen D. Ham-Wasserman lecture: role of the plasminogen system in fibrin-homeostasis and tissue remoldeling (American Society of Hematology Educuation Program). Hematology 2001; 1: 1–9
   Google Scholar
• Dekkers PE, ten Hove T, te Velde AA, van Deventer SJ, van Der Poll T. Upregulation of monocyte urokinase plasminogen activator receptor during human endotoxemia. Infect Immun 2000; 68: 2156–2160
   PubMedGoogle Scholar
• Deininger MH, Trautmann K, Magdolen V, Luther T, Schluesener HJ, Meyermann R. Cortical neurons of Creutzfeldt-Jakob disease patients express the urokinase-type plasminogen activator receptor. Neurosci Lett 2002; 324: 80–82
   Google Scholar
• Fauser S, Deininger MH, Kremsner PG, Magdolen V, Luther T, Meyermann R, Schluesener HJ. Lesion associated expression of urokinase-type plasminogen activator recetor (uPAR, CD87) in human cerebral malaria. J Neuroimmunol 2000; 111: 234–240
   Google Scholar
• Garcia-Monco J, Coleman J, Benach J. Solubile urokinase receptor (uPAR, CD87) is present in serum and cerebrospinal fluid in patients with neurological diseases. J Neuroimmunol 2002; 129: 216–223
   PubMed Web of Science ®Google Scholar
• Gveric D, Hanemaaijer R, Newcombe J, van Lent NA, Sier CF, Cuzner ML. Plasminogen activators in multiple sclerosis lesions: implication for the infammatory response and axonal damage. Brain 2001; 124: 1978–1988
   Google Scholar
• Leduc D, Beaufort N, de Bentzmann S, Rousselle JC, Namane A, Chignard M, Pidard D. The Pseudomonas aeruginosa LasB metalloproteinase regulates the human urokinase-type plasminogen activator receptor through domain-specific endoproteolysis. Infect Immun 2007; 75: 3848–3858
   PubMed Web of Science ®Google Scholar
• Lemstra AW, Groen in't Woud J, Hoozemans J, van Haastert ES, Rozemuller A, Eikelenboom P, van Gool W 2007. Microglia activation in sepsis: a case-control study. J Neuroinflamm Au:4: 4.
   PubMed Web of Science ®Google Scholar
• Madsen CD, Ferraris GM, Andolfo A, Cunningham O, Sidenius N. uPAR-induced cell adhesion and mgration: vitronectin provides the key. J Cell Biol 2007; 177: 927–939
   PubMed Web of Science ®Google Scholar
• Mohanam S, Go Y, Sawaya R, Venkaiah B, Mohan PM, Kouraklis GP, Gokaslan ZL, Lagos GK, Rao JS. Elevated levels of urokinase-type plasminogen activator and its receptor during tumor growth in vivo. Int J Oncol 1999; 14: 169–174
   Google Scholar
• Nebuloni M, Pellegrinelli A, Ferri A, Tosoni A, Bonetto S, Zerbi P, Boldorini R, Vago L, Costanzi G. Etiology of microglial nodules in brains of patients with acquired immunodeficiency sindrome. J NeuroVirol 2000; 6: 46–50
   Google Scholar
• Notter HS. Interaction between macrophages and brain microvascular endothelial cells: role in pathogenesisof HIV-1 infection and blood-brain barrier function. J NeuroVirol 1999; 5: 659–669
   Google Scholar
• Ostergaard C, Benfield T, Lundgren JD, Eugen-Olsen J. Soluble urokinase receptor is elevated in cerebrospinal fluid from patients with purulent meningitis and it is associated with fatal outcome. Scand J Infect Dis 2004; 36: 14–19
   PubMed Web of Science ®Google Scholar
• Ostrowski SR, Piironen T, Hoyer-Hansen G, Gerstoft J, Pedersen BK, Ullum H. Reduced release of intact and cleaved urokinase receptor in stimulated whole-blood cultures from human immunodeficinecy virus-1-infected patients. Scand J Immunol 2005; 61: 347–356
   Google Scholar
• Paul R, Winkler F, Bayerlein I, Popp B, Pfister HW, Koedel U. Urokinase-type plasminogen activator receptor regulates leukocytes recruitment during experimental pneumococcal meningitis. J Infect Dis 2005; 191: 776–782
   PubMed Web of Science ®Google Scholar
• Plesner T, Ralfkiaer E, Wittrup M, Johnsen H, Pyke C, Pedersen TL, Hansen NE, Dano K. Expression of the receptor for urokinase-type plasminogen activator in norma and neoplastic blood cells and hematopoietic tissue. Am J Clin Pathol 1994; 102: 835–841
   PubMedGoogle Scholar
• Resnati M, Pallavicini I, Wang JM, Oppenheim J, Serhan CN, Romano M, Blasi F. The fibrinolytic receptor for urokinase activates the G protein-couples chemotactic receptor FPRL1/LXA4R. Proc Natl Acad Sci U S A 2002; 99: 1359–1364
   PubMed Web of Science ®Google Scholar
• Sidenius N, Nebuloni M, Sala S, Zerbi P, Price RW, Gisslen M, Hagberg L, Vago L, Lazzarin A, Blasi F, Cinque P. Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease. J Neuroimmunol 2004; 157: 133–139
   Google Scholar
• Speth C, Pichler I, Stockl G, Mair M, Dierich MP. Urokinase plasminogen activator receptor 8uPAR; CD87) expression on monocytic cells and T cells is modulated by HIV-1 infection. Immunobiology 1998; 199: 152–162
   PubMed Web of Science ®Google Scholar
• Wada M, Wada NA, Shirono H, Tanigichi K, Tsuchie H, Koga J. Amino-terminal fragment of urokinase-type plasminogen activator inhibits HIV-1 replication. Biochem Biophys Res Commun 2001; 284: 346–351
   PubMed Web of Science ®Google Scholar
• Walker DG, Lue LF, Beach TG. Increased expression of the urokinase plasminogen-activator receptor in amyloid beta peptide-treated human brain microglia and in AD brains. Brain Res 2002; 926: 69–79
   PubMedGoogle Scholar
• Winkler F, Kastenbauer S, Koedel U, Pfister HW. Role of the urokinase plasminogen activator system in patients with bacterial meningitis. Neurology 2002; 59: 1350–1355
   PubMed Web of Science ®Google Scholar